Colorectal Neoplasms
2 competing products in clinical development for Colorectal Neoplasms.
Pipeline by Phase
Phase 11
Phase 31
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| pembrolizumab + lenvatinib + regorafenib + TAS-102 (trifluridine and tipiracil) | Eisai | Phase 3 | Completed | 40 |
| CS-1008 | Daiichi Sankyo | Phase 1 | Completed | 29 |